The game plan set up by North Union went pretty much as scripted in the first half of its Central District Division V sectional final at Bishop Ready on Saturday. That plan was to keep the game at a ...
Topline data of investigator-initiated study at the University of Minnesota and City of Hope demonstrates 86% overall response rate (OR), including 57% complete response ...
Wall Street is mired in another panic over AI. And we contrarians are here for it. Our play? This closed end fund yielding ...
Exercise with Sassy Seniors begins with sharing news, stories, and jokes before the warmup and stretching begins. The group enjoys the camaraderie as much as the workout with bands, weights and balls.
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...
It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...
The Stanford University Board of Trustees has elected two new members, Claire Thielke ’08 M.S. ’08 M.S. ’09 and Jeffrey Bird ’82 Ph.D. ’88 M.D. ’92. The pair will begin their five-year terms on April ...
The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032, registering a CAGR of 7.47% during 2024--2032. Growth is underpinned by ...
Poor shooting and untimely fouls ultimately doomed the Bowling Green Christian Academy’s varsity boys basketball team on ...
The VDH has not answered questions about how much money it erroneously overbilled a pharmaceutical manufacturer and may have to pay back, despite the issue triggering significant cuts to HIV services.
In the latest trading session, Gilead Sciences (GILD) closed at $147.83, marking a -1.46% move from the previous day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results